[Impact of the COVID-19 Outbreak on the management of patients with gynecological cancers].
Impact de la pandémie de Covid-19 sur les modifications thérapeutiques des patientes atteintes de cancers gynécologiques.
Antineoplastic Agents
Betacoronavirus
Breast Neoplasms
/ epidemiology
COVID-19
Coronavirus Infections
/ epidemiology
Female
France
/ epidemiology
Genital Neoplasms, Female
/ epidemiology
Gynecologic Surgical Procedures
/ statistics & numerical data
Humans
Middle Aged
Pandemics
Patient Compliance
/ statistics & numerical data
Pneumonia, Viral
/ epidemiology
Prospective Studies
Radiotherapy
/ statistics & numerical data
Remote Consultation
/ statistics & numerical data
SARS-CoV-2
Withholding Treatment
/ statistics & numerical data
Breast cancer
COVID-19
Cancer du sein
Cancer gynécologique
Coronavirus
Covid-19
Gynecological cancer
Pandemic period
Pandémie
SARS-Cov-2
Journal
Gynecologie, obstetrique, fertilite & senologie
ISSN: 2468-7189
Titre abrégé: Gynecol Obstet Fertil Senol
Pays: France
ID NLM: 101693805
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
24
07
2020
pubmed:
4
10
2020
medline:
20
11
2020
entrez:
3
10
2020
Statut:
ppublish
Résumé
The exceptional health situation related to the SARS-Cov2 coronavirus pandemic (COVID-19) required a deep and very quickly adaptation of management practices in gynecological cancer. The main objective is to estimate the proportion of patients with treatment modifications. This is a multicenter prospective study conducted in 3 university gynecological cancer departments (HCLyon, France) during the period of confinement (March 16 to May 11, 2020). All patients with non-metastatic breast cancer or gynecological cancer were included. The planned treatment, postponement, delay and organizational modifications (RCP, teleconsultations) were studied. Two hundred and five consecutive patients were included, average age 60.5±1.0. 7 patients (3.4%) had SARS-Cov-2 infection, 2 patients died. One hundred and twenty-two patients (59.5%) had a treatment maintained, 72 patients (35.1%) postponed, 11 patients (5.4%) cancelled. Of the 115 (56.1%) planned surgeries, 40 (34.8%) postponed, 7 cancelled (6.1%). 9 patients (7.8%) had a surgical modification. Of the 59 (28.8%) radiotherapy treatments scheduled, 24 (40.7%) postponed and 2 (3.4%) cancelled. Of the 56 (27.3%) chemotherapy treatment planned, 8 (14.3%) postponed and 2 (3.6%) cancelled. One hundred and forty-five patients (70.7%) have been discussed in multidisciplinary meeting. One hundred and fifty-eight patients (77%) had a teleconsultation system. Our study assessed the impact of the COVID-19 pandemic on therapeutic management of patients with gynecological cancer during the period of confinement. This will probably improve our management of an eventual epidemic rebound or future health crisis.
Identifiants
pubmed: 33010487
pii: S2468-7189(20)30268-3
doi: 10.1016/j.gofs.2020.09.011
pmc: PMC7526595
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Multicenter Study
Langues
fre
Sous-ensembles de citation
IM
Pagination
777-783Informations de copyright
Copyright © 2020 Elsevier Masson SAS. All rights reserved.
Références
Bull Cancer. 2020 Apr;107(4):400-402
pubmed: 32229048
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
J Gynecol Obstet Hum Reprod. 2019 Jun;48(6):379-386
pubmed: 30936025
Br J Surg. 2020 Jun;107(7):785-787
pubmed: 32191340
J Clin Oncol. 2009 Jan 1;27(1):16-23
pubmed: 19018080
Eur J Cancer. 2015 Mar;51(4):451-63
pubmed: 25605582
Infect Dis (Lond). 2019 Jul;51(7):502-509
pubmed: 31081422
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
J Gynecol Oncol. 2020 May;31(3):e59
pubmed: 32242340
Radiother Oncol. 2016 Jul;120(1):114-8
pubmed: 27046390
Gynecol Obstet Fertil Senol. 2020 May;48(5):444-447
pubmed: 32222433
Bull Cancer. 2020 May;107(5):528-537
pubmed: 32278467
Lancet Oncol. 2013 Oct;14(11):1086-1094
pubmed: 24055415
J Gynecol Obstet Hum Reprod. 2020 Jun;49(6):101729
pubmed: 32247066